Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
Discounts
News
Outbreaks
Vaccines
AV7909 Anthrax Vaccine
AV7909 Anthrax Vaccine
Fact checked by
Robert Carlson, MD
Apr 30
3 min read
Anthrax Treatment Cocktail Found Immunogenetic
Raxibacumab combines with Anthrax Vaccine Adsorbed does not negatively affect the vaccine immunogenicity
Anthrax
Fact checked by
Danielle Reiter, RN
Nov 8
5 min read
St. Louis Prepares For Potential Anthrax Event
Emergency responders are at high risk of contracting anthrax during a bioterrorism event
Anthrax
Fact checked by
Robert Carlson, MD
Aug 1
4 min read
BARDA Exercises $261 Million Dollar Option for Innovative Anthrax Vaccine
Emergent BioSolutions AV7909 anthrax vaccine being added to the Strategic National Stockpile
Anthrax
Fact checked by
Robert Carlson, MD
May 17
3 min read
BARDA to Purchase Anthrax Vaccine for Strategic Stockpile
Emergent Anthrax Vaccine AV7909 consists of Anthrax Vaccine Adsorbed drug substance and CPG 7909 adjuvant
Anthrax
Clinical Trials
Fact checked by
Robert Carlson, MD
May 3
2 min read
Therapeutic Anthrax Vaccine Candidate Launches Phase 3 Study
AV7909 vaccine is being developed for post-exposure prophylaxis of disease resulting from Bacillus anthracis exposure
Anthrax
Show more